Janney Montgomery Scott Raises Danaher (DHR) Price Target to $174.00

Danaher (NYSE:DHR) had its price objective upped by Janney Montgomery Scott from $136.00 to $174.00 in a research report released on Wednesday morning, LiveTradingNews reports. Janney Montgomery Scott currently has a buy rating on the conglomerate’s stock.

Other analysts have also recently issued research reports about the stock. Zacks Investment Research raised shares of Danaher from a hold rating to a buy rating and set a $147.00 target price on the stock in a report on Tuesday, April 9th. Cowen reaffirmed a buy rating and issued a $110.00 target price on shares of Danaher in a report on Monday, January 7th. Needham & Company LLC reaffirmed a buy rating and issued a $141.00 target price (up previously from $138.00) on shares of Danaher in a report on Wednesday. Deutsche Bank raised their target price on shares of Danaher to $130.00 and gave the company a buy rating in a report on Tuesday, February 26th. Finally, Royal Bank of Canada reaffirmed a hold rating and issued a $102.00 target price on shares of Danaher in a report on Wednesday, December 19th. One equities research analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the stock. The stock presently has an average rating of Buy and an average target price of $131.75.

NYSE DHR opened at $126.77 on Wednesday. The company has a quick ratio of 1.07, a current ratio of 1.47 and a debt-to-equity ratio of 0.34. Danaher has a one year low of $94.59 and a one year high of $134.50. The company has a market capitalization of $90.73 billion, a PE ratio of 28.05, a price-to-earnings-growth ratio of 2.32 and a beta of 1.04.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Thursday, April 18th. The conglomerate reported $1.07 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.01 by $0.06. Danaher had a net margin of 12.04% and a return on equity of 11.85%. The business had revenue of $4.88 billion during the quarter, compared to analyst estimates of $4.80 billion. During the same quarter last year, the firm posted $0.99 earnings per share. The business’s revenue for the quarter was up 3.9% compared to the same quarter last year. Equities research analysts anticipate that Danaher will post 4.78 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 26th. Shareholders of record on Friday, March 29th will be issued a dividend of $0.17 per share. The ex-dividend date is Thursday, March 28th. This represents a $0.68 dividend on an annualized basis and a yield of 0.54%. This is a boost from Danaher’s previous quarterly dividend of $0.16. Danaher’s dividend payout ratio (DPR) is presently 15.04%.

In other Danaher news, EVP Daniel L. Comas sold 97,357 shares of the firm’s stock in a transaction that occurred on Wednesday, February 27th. The shares were sold at an average price of $127.04, for a total transaction of $12,368,233.28. Following the sale, the executive vice president now owns 134,039 shares of the company’s stock, valued at $17,028,314.56. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, SVP Angela S. Lalor sold 4,534 shares of the firm’s stock in a transaction that occurred on Wednesday, February 27th. The stock was sold at an average price of $127.25, for a total transaction of $576,951.50. Following the sale, the senior vice president now directly owns 21,209 shares in the company, valued at approximately $2,698,845.25. The disclosure for this sale can be found here. In the last three months, insiders have sold 183,150 shares of company stock worth $23,279,637. 11.40% of the stock is owned by corporate insiders.

Hedge funds have recently added to or reduced their stakes in the business. CX Institutional raised its holdings in Danaher by 188.7% during the first quarter. CX Institutional now owns 205 shares of the conglomerate’s stock worth $27,000 after purchasing an additional 134 shares in the last quarter. Laurel Wealth Advisors LLC acquired a new stake in Danaher during the fourth quarter worth approximately $27,000. Hanson McClain Inc. raised its holdings in Danaher by 852.9% during the fourth quarter. Hanson McClain Inc. now owns 324 shares of the conglomerate’s stock worth $33,000 after purchasing an additional 290 shares in the last quarter. Executive Wealth Management LLC acquired a new stake in Danaher during the fourth quarter worth approximately $39,000. Finally, Ruggie Capital Group acquired a new stake in Danaher during the fourth quarter worth approximately $40,000. 77.59% of the stock is currently owned by institutional investors.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.

Recommended Story: How Important is Technical Analysis of Stocks

Analyst Recommendations for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.